The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
A Clinical Trial of Beta Carotene to Prevent Basal-Cell and Squamous-Cell Cancers of the Skin
Open accessAbstract
BACKGROUND: Beta carotene has been associated with a decreased risk of human cancer in many studies employing dietary questionnaires or blood measurements, and it has had protective effects in some animal models of carcinogenesis. METHODS: We tested the possible cancer-preventing effects of beta carotene by randomly assigning 1805 patients who had had a recent nonmelanoma skin cancer to receive either 50 mg of beta carotene or placebo per day and by conducting annual skin examinations to determine the occurrence of new nonmelanoma skin cancer. RESULTS: Adherence to the prescribed treatment was good, and after one year the actively treated group's median plasma beta carotene level (3021 nmol per liter) was much higher than that of the control group (354 nmol per liter). After five years of follow-up, however, there was no difference between the groups in the rate of occurrence of the first new nonmelanoma skin cancer (relative rate, 1.05; 95 percent confidence interval, 0.91 to 1.22). In subgroup analyses, active treatment showed no efficacy either in the patients whose initial plasma beta carotene level was in the lowest quartile or in those who currently smoked. There was also no significant difference between treated and control groups in the mean number of new nonmelanoma skin cancers per patient-year. CONCLUSIONS: In persons with a previous nonmelanoma skin cancer, treatment with beta carotene does not reduce the occurrence of new skin cancers over a five-year period of treatment and observation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In other research, treatment with β-carotene did not significantly reduce the occurrence of new skin cancers in persons with previous non-melanoma skin cancer [242].”
From Bioactive Compounds for Skin Health: A Review (2021) · cites this paper as [242]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cox, D. R., & Oakes, D. (2018) · Chapman & Hall/CRC eBooks · doi:10.1201/9781315137438 · Cited by 6,269
Statistical Methods for Survival Data Analysis.
Lachenbruch, P. A., & Lee, E. T. (1993) · Journal of the American Statistical Association · doi:10.2307/2290742 · Cited by 2,851
β-Carotene: an Unusual Type of Lipid Antioxidant
Burton, G. W., & Ingold, K. U. (1984) · Science · doi:10.1126/science.6710156 · Cited by 2,150
Can dietary beta-carotene materially reduce human cancer rates?
Peto, R., Doll, R., Buckley, J. D., & Sporn, M. B. (1981) · Nature · doi:10.1038/290201a0 · Cited by 1,563
A Review of Epidemiologic Evidence that Carotenoids Reduce the Risk of Cancer
Ziegler, R. G. (1989) · Journal of Nutrition · doi:10.1093/jn/119.1.116 · Cited by 552
Hirayama, T. T. (1979) · Nutrition and Cancer · doi:10.1080/01635587909513632 · Cited by 547
Serum Beta-Carotene, Vitamins a and E, Selenium, and the Risk of Lung Cancer
Menkes, M., Comstock, G. W., Vuilleumier, J. P., Helsing, K. J., Rider, A. A., & Brookmeyer, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198611133152003 · Cited by 537
Dietary vitamin a and human lung cancer
Bjelke, E. (1975) · International Journal of Cancer · doi:10.1002/ijc.2910150405 · Cited by 395
Relation of Serum Vitamins a and E and Carotenoids to the Risk of Cancer
Willett, W. C., Polk, B. F., Underwood, B. A., Stampfer, M. J., Pressel, S., ROSNER, B. A., Taylor, J. O., Schneider, K. A., & Hames, C. G. (1984) · New England Journal of Medicine · doi:10.1056/nejm198402163100705 · Cited by 356
Willett, W. C., & MacMahon, B. (1984) · New England Journal of Medicine · doi:10.1056/nejm198403083101006 · Cited by 327
Research works printed but not linked: 9
- Wald, 1987, Cancer Surv, 6, 635
- Shekelle, 1981, Lancet, 2, 1186
- Wang, 1985, Chin Med J [Engl], 98, 206
- Paganini-Hill, 1987, J Natl Cancer Inst, 79, 443
- Stahelin, 1984, J Natl Cancer Inst, 73, 1463
- Nomura, 1985, Cancer Res, 45, 2369
- Mantel, 1966, Cancer Chemother Rep, 50, 163
- SAS Institute Inc. SUGI supplemental library user's guide, version 5 edition. Cary, N.C.: SAS Institute, 1986:437–65.
- Scotto J, Fraumeni JF Jr. Skin (other than melanoma). In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer epidemiology and prevention. Philadelphia: W.B. Saunders, 1982:996–1011.
Cited by
Sorted by citations
Hennekens, C. H., Buring, J. E., Manson, J. E., Stampfer, M., Rosner, B., Cook, N. R., Belanger, C., LaMotte, F., Gaziano, J. M., Ridker, P. M., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605023341801 · Cited by 2,397
Bjelakovic, G., Nikolova, D., Gluud, L. L., Simonetti, R. G., & Gluud, C. (2007) · JAMA · doi:10.1001/jama.297.8.842 · Cited by 2,275
Potential Synergy of Phytochemicals in Cancer Prevention: Mechanism of Action
Liu, R. H. (2004) · Journal of Nutrition · doi:10.1093/jn/134.12.3479s · Cited by 2,295
Liu, R. H. (2003) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/78.3.517s · Cited by 2,213
The causes and prevention of cancer.
Ames, B. N., Gold, L. S., & Willett, W. C. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5258 · Cited by 1,325
Metadata
- Authors
- Greenberg, E. R., Baron, J. A., Stukel, T. A., Stevens, M. M., Mandel, J. S., Spencer, S. K., Elias, P. M., Lowe, N., Nierenberg, D. W., Bayrd, G., Vance, J. C., Freeman, D. H., Clendenning, W. E., & Kwan, T.
- Affiliations
- Dartmouth College (US)
- University of Minnesota (US)
- University of California, San Francisco (US)
- University of California, Los Angeles (US)
- Harvard University (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1990-09-20
- Volume
- 323
- Issue
- 12
- Pages
- 789-795
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2313686482
- Cited by
- 482
- References
- 35
- Citations by year
- 2025: 2 · 2024: 3 · 2023: 8 · 2022: 10 · 2021: 4 · 2020: 7 · 2019: 3 · 2018: 3 · 2017: 6 · 2016: 8 · 2015: 13 · 2014: 11 · 2013: 7 · 2012: 21
- FWCI
- 18.92
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5u01ca032934-10)
- National Cancer Institute (CA-32934, CA 23 108, P30CA023108)
- Topics
- Health Sciences › Medicine › Dermatology › Nonmelanoma Skin Cancer Studies
- Health Sciences › Medicine › Dermatology › Skin Protection and Aging
- Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
- Keywords
- beta-carotene, non-melanoma skin cancer, basal cell carcinoma, squamous cell carcinoma, cancer prevention, chemoprevention, smoking, medication adherence
- MeSH terms
- Aged, Basal Cell Carcinoma, Carcinoma, Squamous Cell, Carotenoids, Drug Evaluation, Female, Follow-Up Studies, Humans, Male, Patient Compliance, Recurrence, Skin Neoplasms, Randomized Controlled Trials as Topic, beta Carotene
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
